BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25961436)

  • 41. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
    Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
    Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy.
    Cappella M; Pradat PF; Querin G; Biferi MG
    J Neuromuscul Dis; 2021; 8(1):25-38. PubMed ID: 33074186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.
    Pandya RS; Mao LL; Zhou EW; Bowser R; Zhu Z; Zhu Y; Wang X
    Cent Nerv Syst Agents Med Chem; 2012 Mar; 12(1):15-27. PubMed ID: 22283698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Research advances in amyotrophic lateral sclerosis, 2009 to 2010.
    Traub R; Mitsumoto H; Rowland LP
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):67-77. PubMed ID: 21080240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Full Issue PDF, Volume 18, Issue S1.
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):1-103. PubMed ID: 28872910
    [No Abstract]   [Full Text] [Related]  

  • 46. We have a problem: why have ALS trials been negative?
    Swash M
    Amyotroph Lateral Scler; 2007 Oct; 8(5):259. PubMed ID: 17917847
    [No Abstract]   [Full Text] [Related]  

  • 47. Biological markers in amyotrophic lateral sclerosis: help or hindrance?
    Bradley WG
    J Neurol; 1999 Nov; 246 Suppl 3():III13-5. PubMed ID: 10631655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amyotrophic lateral sclerosis: clinical management and research update.
    Andrews J
    Curr Neurol Neurosci Rep; 2009 Jan; 9(1):59-68. PubMed ID: 19080755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-led research in amyotrophic lateral sclerosis: Quo vadis?
    Stefanou MI; Amygdalos I
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):418-22. PubMed ID: 25800785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene and protein therapies utilizing VEGF for ALS.
    Keifer OP; O'Connor DM; Boulis NM
    Pharmacol Ther; 2014 Mar; 141(3):261-71. PubMed ID: 24177067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyotrophic lateral sclerosis: theories and therapies.
    Rowland LP
    Ann Neurol; 1994 Feb; 35(2):129-30. PubMed ID: 8109893
    [No Abstract]   [Full Text] [Related]  

  • 52. RNA-targeted Therapeutics for ALS.
    Reddy LV; Miller TM
    Neurotherapeutics; 2015 Apr; 12(2):424-7. PubMed ID: 25753730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finding a Treatment for ALS - Will Gene Editing Cut It?
    Al-Chalabi A; Brown RH
    N Engl J Med; 2018 Apr; 378(15):1454-1456. PubMed ID: 29641956
    [No Abstract]   [Full Text] [Related]  

  • 54. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.
    Shook SJ; Pioro EP
    Ann Neurol; 2009 Jan; 65 Suppl 1():S10-6. PubMed ID: 19191305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ALSUntangled no. 49: resveratrol.
    ALSUNTANGLED GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):619-624. PubMed ID: 30945567
    [No Abstract]   [Full Text] [Related]  

  • 56. RNAi therapy: dominant disease gene gets silenced.
    Xu Z; Xia XG
    Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
    [No Abstract]   [Full Text] [Related]  

  • 57. Gene therapy for amyotrophic lateral sclerosis.
    Federici T; Boulis NM
    Neurobiol Dis; 2012 Nov; 48(2):236-42. PubMed ID: 21889591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.
    Orrell RW; Lane RJ; Ross M
    Amyotroph Lateral Scler; 2008 Aug; 9(4):195-211. PubMed ID: 18608090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.
    Orrell RW; Lane RJ; Ross M
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002829. PubMed ID: 17253482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyotrophic lateral sclerosis.
    van Es MA; Hardiman O; Chio A; Al-Chalabi A; Pasterkamp RJ; Veldink JH; van den Berg LH
    Lancet; 2017 Nov; 390(10107):2084-2098. PubMed ID: 28552366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.